Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
7
×
national blog main
national top stories
san francisco top stories
biotech
new york top stories
san francisco blog main
texas blog main
texas top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
cancer
clinical trials
gene therapy
novartis
amgen
biogen
deals
fda
medicare
merck
pfizer
roche
spark therapeutics
What
patients
7
×
drug
bio
roundup
fda
medicine
therapy
cancer
gene
market
moves
new
acquisitions
advantages
albert
allison
approved
aren’t
atrophy
bar
becker
biggest
billions
bourla
brings
cancers
ceo
company
countless
crispr
daily
developers
dollars
drugs
eaton
eisai
evrysdi
expect
fight
flags
Language
unset
unknown
Current search:
national
×
patients
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More